Patients With High-disease-activity Relapsing-Remitting Multiple Sclerosis in Real-world Clinical Practice: A Population-based Study in Sweden

首页> 外文期刊>Clinical therapeutics >Patients With High-disease-activity Relapsing-Remitting Multiple Sclerosis in Real-world Clinical Practice: A Population-based Study in Sweden

【24h】

Patients With High-disease-activity Relapsing-Remitting Multiple Sclerosis in Real-world Clinical Practice: A Population-based Study in Sweden

机译：高疾病活性患者在现实世界临床实践中复发 - 延缓多发性硬化：瑞典的基于人口的研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: This study aims to compare the disease progression and disease-modifying treatmente switching patterns between patients with highdisease-activity (HDA) relapsing-remitting multiple sclerosis (RRMS) and patients with low-diseaseactivity (LDA) RRMS in real-world clinical practice.

机译：目的：本研究旨在比较患有高酶活性（HDA）患者之间的疾病进展和疾病修饰治疗切换模式，复发 - 在现实世界临床实践中复发 - 饲养多发性硬化症（RRMS）和低疾病（LDA）RRMS的患者。

著录项

来源
《Clinical therapeutics》 |2020年第2期|共11页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
Disease-modifying treatment; Multiple sclerosis; Relapsing-remitting multiple sclerosis; High disease activity;

机译：疾病改性治疗;多发性硬化症;复发 - 延缓多发性硬化;高疾病活动;

相似文献

外文文献
中文文献
专利

1. Patients With High-disease-activity Relapsing-Remitting Multiple Sclerosis in Real-world Clinical Practice: A Population-based Study in Sweden [J] . Clinical therapeutics . 2020,第2期

机译：高疾病活性患者在现实世界临床实践中复发 - 延缓多发性硬化：瑞典的基于人口的研究
2. DELAYED-RELEASE DIMETHYL FUMARATE DEMONSTRATED NO DIFFERENCE IN CLINICAL OUTCOMES VERSUS FINGOLIMOD IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS: RESULTS FROM THE REAL-WORLD EFFECT STUDY [J] . Sloane Jacob, Phillips J. Theodore, Calkwood Jonathan, Journal of Neurology, Neurosurgery and Psychiatry . 2018,第6期

机译：延迟释放二甲基富马酸盐证明临床结果对慢性多发性硬化症患者的临床结果与Fingolimod的差异显示：现实世界效应研究的结果
3. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis [J] . Planche V., Gibelin M., Cregut D., European journal of neurology: the official journal of the European Federation of Neurological Societies . 2016,第2期

机译：一项基于人群的多发性硬化症患者研究中的认知障碍：晚期复发型，继发性进行性和原发性进行性多发性硬化症之间的差异
4. Biclustering-Based Classification of Clinical Expression Time Series: A Case Study in Patients with Multiple Sclerosis [C] . Andre V. Carreiro, Orlando Anunciacao, Joao A. Carrico, 5th international conference on practical applications of computational biology amp; bioinformatics . 2011

机译：基于Biclustering的临床表达时间序列分类：以多发性硬化症患者为例
5. An investigation of early relapsing-remitting multiple sclerosis patients using diffusion tensor imaging and spectroscopy. [D] . Zaini, Wan Hazlin. 2013

机译：使用扩散张量成像和光谱法对早期复发缓解型多发性硬化症患者进行调查。
6. Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study [O] . Bianca Weinstock-Guttman, Jennie Medin, Nasreen Khan, -1

机译：在常规临床实践中评估接受芬戈莫德复发-缓解的多发性硬化症患者的无疾病活动证据状态：美国多发性硬化症临床和磁共振成像结果的回顾性分析（MS-MRIUS）
7. Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study [O] . Francisco Barrero, Javier Mallada-Frechin, María Luisa Martínez-Ginés, 2020

机译：西班牙现实世界与佛教司典经验复发 - 延髓多发性硬化症患者：下一步研究

Patients With High-disease-activity Relapsing-Remitting Multiple Sclerosis in Real-world Clinical Practice: A Population-based Study in Sweden

摘要

著录项

相似文献

相关主题

期刊订阅